Aditi Hazra/poster.bwh.harvard.edu
Jun 21, 2025, 12:51
Aditi Hazra: Displaced People Must Not Remain Invisible in Cancer Clinical Trials
Aditi Hazra, Assistant Director at VA COURAGE and Assistant Professor at Harvard Medical School, shared a post on LinkedIn:
“Over 123 million people worldwide are forcibly displaced, yet displaced persons remain almost invisible in cancer clinical trials. As highlighted in the Science Letter and UNHCR Pledge GRF-0026, to minimize trial disruptions and address global inequities, cancer clinical trial oncologists, researchers, regulatory authorities, and industry partners must bring the trial to the patient.
By using decentralized trial sites, patient navigators, and digital technology, we can reach displaced and underserved populations, ensuring access to life-saving research and care for all. Building an inclusive clinical trial infrastructure strengthens cancer care for every community.”
More posts featuring Aditi Hazra.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 21, 2025, 11:56
Jun 21, 2025, 11:47
Jun 21, 2025, 11:07
Jun 21, 2025, 10:30
Jun 21, 2025, 08:57